about
Smoking, dementia and cognitive decline in the elderly, a systematic reviewFracture risk and the use of a diuretic (indapamide SR) +/- perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET)Alcohol, dementia and cognitive decline in the elderly: a systematic reviewIncident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trialHaemoglobin, anaemia, dementia and cognitive decline in the elderly, a systematic review.Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET).Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population useIs it advantageous to lower cholesterol in the elderly hypertensive?Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients.Prevention of stroke.Treatment of hypertension in patients 80 years of age or older.The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies.Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia.The measurement of adult blood pressure and management of hypertension before elective surgery: Joint Guidelines from the Association of Anaesthetists of Great Britain and Ireland and the British Hypertension Society.Hypertension, dementia, and antihypertensive treatment: implications for the very elderly.Treating hypertension in the very elderly-benefits, risks, and future directions, a focus on the hypertension in the very elderly trial.Corrigenda: Corrigendum to 'The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies'.Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial.Increased pulse pressure linked to dementia: further results from the Hypertension in the Very Elderly Trial - HYVET.Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial.Baseline characteristics of participants in the Hypertension in the Very Elderly Trial (HYVET).Impact of transiently elevated diastolic pressure on cause of death: 29-year follow-up from the General Practice Hypertension Study Group.The clock drawing test, mortality, incident cardiovascular events and dementia.Response to HYVET ambulatory blood pressure substudy.Characteristics of the Chinese subjects entered the hypertension in the very elderly trial.Romanian subjects entered in the hypertension in the very elderly trial (HYVET).A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial.Antihypertensive treatment decreases arterial stiffness at night but not during the day. Results from the Hypertension in the Very Elderly Trial.Surrogates' decisions regarding CPR, and the fallacy of substituted judgment.Does White Coat Hypertension Require Treatment Over Age 80?Despite evidence-based guidelines, systolic blood pressure remains inadequately controlled in older hypertensive adultsNo evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, pLeft ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.Elevated sweat potassium, hyperaldosteronism and pseudo-Bartter's syndrome: a spectrum of disorders associated with cystic fibrosisOrthostatic fall in blood pressure in the very elderly hypertensive: results from the hypertension in the very elderly trial (HYVET) - pilotBlood pressure control in the Hypertension in the Very Elderly Trial (HYVET)Atrial fibrillation is associated with an increased risk of cognitive and functional decline
P50
Q21261847-AA1EA771-A647-4F87-A20C-A3BDA2692AFEQ28212941-6C76047E-14DB-4BE9-95C4-4042777AA565Q28280497-48F83B80-0AB2-4E91-97D2-F92D5A832344Q28286628-D1B74276-9761-498C-B6EA-29708DD2CC9DQ33358954-94FEE0F0-2A26-4866-B1B2-A872A5D3ED2BQ33585945-07F20C99-8895-4A97-9B43-0CAECB49449EQ33644458-4379AED5-95CC-4D85-B1FB-D4C6ECECDC32Q34041509-2DAB1ADD-693F-404E-A053-B38BCF410A72Q34213671-8AAD2CF6-D83B-404A-A958-7333E4080ADEQ34433711-6DB002E4-5DD2-4D83-B03E-FA1CA3909932Q34766135-5889C20D-4786-4E9D-B074-C758152111C5Q35893532-C1ADD7F0-30EE-4E86-ABDB-272FBA8F202CQ36490441-DBED4EFF-537C-4987-AF0B-FB50A1CC84EBQ37344072-5FD62799-BD03-44C5-BC59-0B3ED9A860BDQ37551271-514E37BB-78B7-4763-88F9-A51BB84D1FAFQ38168493-66E495B1-E120-449F-8D41-6776DA7539AFQ38844251-8F33D51E-4EB6-4EB8-8EA7-9326B6761AE9Q38899324-840716EA-0A3A-40C5-BAF6-9D422A414E59Q39351570-CA54F148-2E10-49DC-843B-6DA08CA5B235Q40057422-6DA6F324-3D1E-40D8-BD6C-BD319E90BC90Q43288486-BC64CEEF-ED96-4254-9108-456F21A520CEQ44165287-A216FF68-E397-4C66-AB7F-1EFAF89EBD9EQ44576409-26B95C70-EA1B-4BA1-9C39-31E911051023Q45212245-79C387E6-A827-426B-9FCE-4D755E33DD6FQ45228962-05CDA1CE-7068-419E-878B-0787D801AAEDQ46265779-84BE50C7-F0F6-487A-9207-2FC82C08BAB2Q46666114-8B27FC17-3573-4AD5-A611-826EA444A42FQ46955454-B90463FE-8D70-410C-B9B8-B8005CE8BF8DQ50593349-A1FC539D-7878-448D-A8A5-13E5F97DFF4EQ53301109-7AFB605F-8391-4805-A62D-67583D3D372BQ57085347-88D73A7F-95A4-4527-A81E-FFBCBCE1CB32Q57747291-12A89D52-EC1C-432D-B1EC-478F278D827AQ59822600-85E21C1C-5269-4198-954B-D145816FC175Q64911375-E9059AB6-8CAD-4C2C-ACB8-A67BF5BC9478Q69615293-BE668927-02B5-40FE-BB7F-909788A84B24Q73318846-9FD1D3FE-660A-4356-8F19-0AC9F73CA281Q83576030-37F3E655-8BD3-4EC2-8363-07A15A0F9915Q84861609-0E48974D-4259-4CFC-B0D1-691F548E032C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nigel S Beckett
@ast
Nigel S Beckett
@en
Nigel S Beckett
@es
Nigel S Beckett
@nl
type
label
Nigel S Beckett
@ast
Nigel S Beckett
@en
Nigel S Beckett
@es
Nigel S Beckett
@nl
prefLabel
Nigel S Beckett
@ast
Nigel S Beckett
@en
Nigel S Beckett
@es
Nigel S Beckett
@nl
P108
P106
P31
P496
0000-0002-7736-3817